Exemption of Specified COVID-19 Drugs from Odisha State GST in Excess of the Prescribed Rates under Section 11(1) of the Odisha Goods and Services Tax Act, 2017 https://www.taxtmi.com/notifications?id=147429 Specified Chapter 30 COVID-19 medicines receive a State GST exemption that limits tax to nil for Tocilizumab and Amphotericin B and to 2.5% for listed other medicines, including Remdesivir, Heparin, Itolizumab, Posaconazole, Infliximab, specified antibody combinations, 2-Deoxy-D-Glucose and Favipiravir. The measure applies from 1 October 2021 through 31 December 2021 inclusive and exempts tax only above those prescribed rates. en-us Mon, 11 Oct 2021 00:00:00 +0530 Sat, 24 Oct 2026 14:03:06 +0530 TaxTMI RSS Generator Exemption of Specified COVID-19 Drugs from Odisha State GST in Excess of the Prescribed Rates under Section 11(1) of the Odisha Goods and Services Tax Act, 2017 https://www.taxtmi.com/notifications?id=147429 Specified Chapter 30 COVID-19 medicines receive a State GST exemption that limits tax to nil for Tocilizumab and Amphotericin B and to 2.5% for listed other medicines, including Remdesivir, Heparin, Itolizumab, Posaconazole, Infliximab, specified antibody combinations, 2-Deoxy-D-Glucose and Favipiravir. The measure applies from 1 October 2021 through 31 December 2021 inclusive and exempts tax only above those prescribed rates. Notifications GST - States Mon, 11 Oct 2021 00:00:00 +0530 https://www.taxtmi.com/notifications?id=147429